当前位置: 首页 > 期刊 > 《新医学》 > 201910
编号:13531336
DIO3基因在肿瘤发病机制中的作用研究进展(3)
http://www.100md.com 2019年10月1日 《新医学》 201910
     四、結 语

    DIO3基因不仅对正常机体发育起作用,而且与多种良恶性肿瘤的发生及发展密切相关。DIO3基因参与的肿瘤调控机制错综复杂,不同调节通路之间往往存在交互作用。但通过调节DIO3基因的表达而改变局部活性甲状腺激素浓度,继而影响细胞的分化和增殖是许多肿瘤发生、发展的共同机制。关于DIO3基因在肿瘤中的具体调节通路方面仍有许多亟待解决的问题。矫正DIO3基因的异常表达或增加活性甲状腺激素浓度可能成为某些肿瘤治疗的新途径,但需要更多的研究提供支持。

    参 考 文 献

    [1] Conesa-Zamora P, García-Solano J, Turpin Mdel C, Sebastián-León P, Torres-Moreno D, Estrada E, Tuomisto A, Wilce J, M?kinen MJ, Pérez-Guillermo M, Conesa A. Methylome profiling reveals functions and genes which are differentially methylated in serrated compared to conventional colorectal carcinoma. Clin Epigenetics, 2015, 17(7):101.
, http://www.100md.com
    [2] Hernández A, Lyon GJ, Schneider MJ, St Germain DL. Isolation and characterization of the mouse gene for the type 3 iodothyronine deiodinase. Endocrinology, 1999,140(1):124-130.

    [3] Ciavardelli D, Bellomo M, Crescimanno C, Vella V. Type 3 deiodinase: role in cancer growth, stemness, and metabolism. Front Endocrinol (Lausanne), 2014,17(5):215.

    [4] Dentice M, Luongo C, Ambrosio R, Sibilio A, Casillo A, Iaccarino A, Troncone G, Fenzi G, Larsen PR, Salvatore D. β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. Gastroenterology, 2012,143(4):1037-1047.
, 百拇医药
    [5] Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, Zavacki AM, Fenzi G, Grachtchouk M, Hutchin M, Dlugosz AA, Bianco AC, Missero C, Larsen PR, Salvatore D. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci U S A, 2007,104(36):14466-14471.

    [6] Romitti M, Wajner SM, Zennig N, Goemann IM, Bueno AL, Meyer EL, Maia AL. Increased type 3 deiodinase expression in papillary thyroid carcinoma. Thyroid, 2012, 22(9):897-904.
, 百拇医药
    [7] Lan X, Xing J, Gao H, Li S, Quan L, Jiang Y, Ding S, Xue Y. Decreased expression of selenoproteins as a poor prognosticator of gastric cancer in humans. Biol Trace Elem Re, 2017,178(1):22-28.

    [8] Romitti M, Wajner SM, Ceolin L, Ferreira CV, Ribeiro RV, Rohenkohl HC, Weber Sde S, Lopez PL, Fuziwara CS, Kimura ET, Maia AL. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma. Endocr Relat Cancer, 2016,23(3):135-146.

    [9] Huang SA, Fish SA, Dorfman DM, Salvatore D, Kozakewich HP, Mandel SJ, Larsen PR. A 21-year-old woman with cons-umptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J Clin Endocrinol Metab, 2002,87(10):445744-445761., 百拇医药(张桂虾?施飞熊?周宇)
上一页1 2 3 4下一页